(1->4)-beta-D-glucan multiple interactions ISO RGD:1623867 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of H6PD mRNA CTD PMID:36331819 (S)-(-)-perillyl alcohol multiple interactions EXP 6480464 perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein] CTD PMID:20923693 17beta-estradiol affects expression ISO RGD:1315252 6480464 Estradiol affects the expression of H6PD mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1623867 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of H6PD mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of H6PD mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1623867 6480464 Tetrachlorodibenzodioxin results in increased expression of H6PD mRNA, Tetrachlorodibenzodioxin results in increased expression of H6PD protein CTD PMID:17949056 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1623867 6480464 Tetrachlorodibenzodioxin affects the expression of H6PD mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1623867 6480464 2 more ... CTD PMID:20702594 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO RGD:1623867 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased activity of H6PD protein] CTD PMID:12547406 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1623867 6480464 3 more ... CTD PMID:23994337 4,4'-diaminodiphenylmethane increases expression ISO RGD:1623867 6480464 4, 4'-diaminodiphenylmethane results in increased expression of H6PD mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1623867 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of H6PD mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1623867 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of H6PD exon CTD PMID:33297965 4-hydroxynon-2-enal decreases activity ISO RGD:1315252 6480464 4-hydroxy-2-nonenal results in decreased activity of H6PD protein CTD PMID:20211231 4-hydroxyphenyl retinamide decreases expression ISO RGD:1623867 6480464 Fenretinide results in decreased expression of H6PD mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of H6PD mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of H6PD mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1315252 6480464 Acrylamide results in decreased expression of H6PD mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1315252 6480464 Aflatoxin B1 results in decreased expression of H6PD mRNA CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1315252 6480464 Aflatoxin B1 results in increased methylation of H6PD intron CTD PMID:30157460 aristolochic acid A decreases expression ISO RGD:1315252 6480464 aristolochic acid I results in decreased expression of H6PD mRNA CTD PMID:33212167 arsane increases methylation ISO RGD:1315252 6480464 Arsenic results in increased methylation of H6PD gene CTD PMID:30746931 arsane affects expression ISO RGD:1315252 6480464 Arsenic affects the expression of H6PD mRNA CTD PMID:30746931 arsenic atom affects expression ISO RGD:1315252 6480464 Arsenic affects the expression of H6PD mRNA CTD PMID:30746931 arsenic atom increases methylation ISO RGD:1315252 6480464 Arsenic results in increased methylation of H6PD gene CTD PMID:30746931 arsenite(3-) increases expression ISO RGD:1315252 6480464 arsenite metabolite results in increased expression of H6PD mRNA CTD PMID:33129825 arsenous acid decreases expression ISO RGD:1315252 6480464 Arsenic Trioxide results in decreased expression of H6PD mRNA CTD PMID:27829220 benzo[a]pyrene decreases activity ISO RGD:1623867 6480464 Benzo(a)pyrene results in decreased activity of H6PD protein CTD PMID:18338764 benzo[a]pyrene affects methylation ISO RGD:1315252 6480464 Benzo(a)pyrene affects the methylation of H6PD 3' UTR, Benzo(a)pyrene affects the methylation of H6PD intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1315252 6480464 Benzo(a)pyrene results in increased methylation of H6PD 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1623867 6480464 Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of H6PD protein] CTD PMID:18338764 benzo[e]pyrene increases methylation ISO RGD:1315252 6480464 benzo(e)pyrene results in increased methylation of H6PD intron CTD PMID:30157460 beta-naphthoflavone increases expression ISO RGD:1623867 6480464 beta-Naphthoflavone results in increased expression of H6PD mRNA CTD PMID:23994337 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1315252 6480464 Diethylhexyl Phthalate results in decreased expression of H6PD protein CTD PMID:31163220 bisphenol A increases expression ISO RGD:1315252 6480464 bisphenol A results in increased expression of H6PD mRNA CTD PMID:24901218 more ... bisphenol A multiple interactions ISO RGD:1315252 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of H6PD gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1623867 6480464 bisphenol A results in increased expression of H6PD mRNA CTD PMID:30951980 more ... bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of H6PD gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:1623867 6480464 bisphenol A affects the methylation of H6PD promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of H6PD mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1623867 6480464 bisphenol F results in increased expression of H6PD mRNA CTD PMID:30951980 bortezomib decreases expression ISO RGD:1315252 6480464 Bortezomib results in decreased expression of H6PD mRNA CTD PMID:20977926 butanal decreases expression ISO RGD:1315252 6480464 butyraldehyde results in decreased expression of H6PD mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1623867 6480464 Cadmium results in decreased expression of H6PD mRNA CTD PMID:24067728 capsaicin multiple interactions ISO RGD:1623867 6480464 Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of H6PD protein] CTD PMID:18338764 carbon nanotube increases expression ISO RGD:1623867 6480464 Nanotubes more ... CTD PMID:25620056 cis-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Cisplatin results in decreased activity of H6PD protein] CTD PMID:21640567 cisplatin multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Cisplatin results in decreased activity of H6PD protein] CTD PMID:21640567 cisplatin decreases activity EXP 6480464 Cisplatin results in decreased activity of H6PD protein CTD PMID:21640567 cobalt dichloride increases expression ISO RGD:1623867 6480464 cobaltous chloride results in increased expression of H6PD mRNA CTD PMID:21139344 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of H6PD mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1623867 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of H6PD mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:1315252 6480464 [Disulfiram binds to Copper] which results in increased expression of H6PD mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1623867 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of H6PD mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1315252 6480464 [Disulfiram binds to Copper] which results in increased expression of H6PD mRNA CTD PMID:24690739 cortisol increases expression ISO RGD:1315252 6480464 Hydrocortisone results in increased expression of H6PD mRNA CTD PMID:20410225 cyclosporin A decreases expression ISO RGD:1315252 6480464 Cyclosporine results in decreased expression of H6PD mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO RGD:1623867 6480464 apicidin inhibits the reaction [Dexamethasone results in increased expression of H6PD mRNA] CTD PMID:23946490 dexamethasone increases expression ISO RGD:1623867 6480464 Dexamethasone results in increased expression of H6PD mRNA CTD PMID:22733784 , PMID:23946490 diarsenic trioxide decreases expression ISO RGD:1315252 6480464 Arsenic Trioxide results in decreased expression of H6PD mRNA CTD PMID:27829220 dicrotophos increases expression ISO RGD:1315252 6480464 dicrotophos results in increased expression of H6PD mRNA CTD PMID:28302478 diethyl maleate increases expression ISO RGD:1623867 6480464 diethyl maleate results in increased expression of H6PD mRNA CTD PMID:25270620 disulfiram multiple interactions ISO RGD:1315252 6480464 [Disulfiram binds to Copper] which results in increased expression of H6PD mRNA CTD PMID:24690739 elemental selenium multiple interactions ISO RGD:1315252 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA CTD PMID:19244175 elemental selenium increases expression ISO RGD:1315252 6480464 Selenium results in increased expression of H6PD mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of H6PD mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1623867 6480464 epoxiconazole results in decreased expression of H6PD mRNA CTD PMID:35436446 ethanol decreases activity EXP 6480464 Ethanol results in decreased activity of H6PD protein CTD PMID:20923693 ethanol multiple interactions EXP 6480464 perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein] CTD PMID:20923693 fenthion decreases expression ISO RGD:1623867 6480464 Fenthion results in decreased expression of H6PD mRNA CTD PMID:34813904 fulvestrant multiple interactions ISO RGD:1315252 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of H6PD gene CTD PMID:31601247 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of H6PD mRNA CTD PMID:22061828 , PMID:33387578 glycidol increases expression EXP 6480464 glycidol results in increased expression of H6PD mRNA CTD PMID:24915197 ivermectin decreases expression ISO RGD:1315252 6480464 Ivermectin results in decreased expression of H6PD protein CTD PMID:32959892 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of H6PD mRNA CTD PMID:24136188 malonaldehyde decreases activity ISO RGD:1315252 6480464 Malondialdehyde results in decreased activity of H6PD protein CTD PMID:20211231 MeIQx decreases expression ISO RGD:1315252 6480464 2-amino-3 more ... CTD PMID:20816883 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of H6PD mRNA CTD PMID:30467583 methapyrilene increases methylation ISO RGD:1315252 6480464 Methapyrilene results in increased methylation of H6PD intron CTD PMID:30157460 nickel atom increases expression ISO RGD:1315252 6480464 Nickel results in increased expression of H6PD mRNA CTD PMID:25583101 paracetamol multiple interactions ISO RGD:1623867 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased activity of H6PD protein] CTD PMID:12547406 paracetamol decreases expression ISO RGD:1315252 6480464 Acetaminophen results in decreased expression of H6PD mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:1623867 6480464 Acetaminophen affects the expression of H6PD mRNA CTD PMID:17562736 paracetamol increases activity ISO RGD:1623867 6480464 Acetaminophen results in increased activity of H6PD protein CTD PMID:12547406 pentanal decreases expression ISO RGD:1315252 6480464 pentanal results in decreased expression of H6PD mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1623867 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of H6PD mRNA CTD PMID:36331819 perillyl alcohol multiple interactions EXP 6480464 perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein] CTD PMID:20923693 pirinixic acid increases expression ISO RGD:1623867 6480464 pirinixic acid results in increased expression of H6PD mRNA CTD PMID:17426115 potassium dichromate increases expression ISO RGD:1315252 6480464 Potassium Dichromate results in increased expression of H6PD protein CTD PMID:23718831 propiconazole decreases expression ISO RGD:1623867 6480464 propiconazole results in decreased expression of H6PD mRNA CTD PMID:21278054 selenium atom multiple interactions ISO RGD:1315252 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA CTD PMID:19244175 selenium atom increases expression ISO RGD:1315252 6480464 Selenium results in increased expression of H6PD mRNA CTD PMID:19244175 serpentine asbestos multiple interactions ISO RGD:1315252 6480464 Asbestos, Serpentine results in increased metabolism of and results in decreased activity of H6PD protein CTD PMID:20211231 silicon dioxide decreases expression ISO RGD:1315252 6480464 Silicon Dioxide analog results in decreased expression of H6PD mRNA, Silicon Dioxide results in decreased expression of H6PD mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of H6PD protein CTD PMID:29459688 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of H6PD mRNA CTD PMID:26141394 temozolomide decreases expression ISO RGD:1315252 6480464 Temozolomide results in decreased expression of H6PD mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases activity ISO RGD:1623867 6480464 tert-Butylhydroperoxide results in increased activity of H6PD protein CTD PMID:15003993 tert-butyl hydroperoxide increases expression ISO RGD:1623867 6480464 tert-Butylhydroperoxide results in increased expression of H6PD mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:1315252 6480464 Testosterone results in increased expression of H6PD mRNA CTD PMID:20410225 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of H6PD mRNA CTD PMID:23411599 , PMID:34492290 trans-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Cisplatin results in decreased activity of H6PD protein] CTD PMID:21640567 triptonide affects expression ISO RGD:1623867 6480464 triptonide affects the expression of H6PD mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1623867 6480464 troglitazone results in decreased expression of H6PD mRNA CTD PMID:28973697 valproic acid increases methylation ISO RGD:1315252 6480464 Valproic Acid results in increased methylation of H6PD gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1315252 6480464 Valproic Acid affects the expression of H6PD mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1315252 6480464 Valproic Acid results in decreased expression of H6PD mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:1623867 6480464 Valproic Acid results in increased expression of H6PD mRNA CTD PMID:21427059 vancomycin decreases expression ISO RGD:1623867 6480464 Vancomycin results in decreased expression of H6PD mRNA CTD PMID:18930951 vitamin E increases expression ISO RGD:1315252 6480464 Vitamin E results in increased expression of H6PD mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1315252 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA CTD PMID:19244175 zidovudine affects expression ISO RGD:1315252 6480464 Zidovudine affects the expression of H6PD mRNA CTD PMID:20032539
